Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,512,440 | $2,386,266 | $3,947,464 | $4,987,438 |
| Dep. & Amort. | $3,001,543 | $3,118,678 | $2,335,911 | $1,834,381 |
| Deferred Tax | $0 | $0 | -$188,498 | -$4,038,579 |
| Stock-Based Comp. | $21,069 | $35,898 | $54,483 | $64,286 |
| Change in WC | -$1,350,815 | -$936,587 | -$1,387,883 | $259,742 |
| Other Non-Cash | -$707,256 | -$240,979 | -$543,907 | $841,479 |
| Operating Cash Flow | $4,476,981 | $3,414,217 | $4,217,571 | $3,948,747 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,410,191 | -$5,336,705 | -$5,888,839 | -$4,972,587 |
| Net Acquisitions | -$84,370 | -$923,699 | -$487,564 | $381,434 |
| Inv. Purchases | -$846,041 | -$942,971 | -$1,501,266 | -$1,424,634 |
| Inv. Sales/Matur. | $1,498,378 | $2,727,597 | $4,649,530 | $2,168,254 |
| Other Inv. Act. | $228,901 | -$302,081 | -$835,899 | -$9,454 |
| Investing Cash Flow | -$3,613,323 | -$4,777,859 | -$4,064,038 | -$3,856,987 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $410,324 | $1,724,181 | $3,747,388 | $1,810,813 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$238,106 | $0 | $0 | $0 |
| Dividends Paid | -$2,059,420 | -$2,455,170 | -$1,435,465 | -$1,102,997 |
| Other Fin. Act. | $884,616 | -$595,752 | $4,603,504 | -$716,260 |
| Financing Cash Flow | -$1,002,586 | -$1,326,740 | $4,428,475 | -$831,279 |
| Forex Effect | $27,989 | $73,645 | $128,342 | -$134,712 |
| Net Chg. in Cash | -$110,939 | -$1,667,678 | $4,710,350 | -$874,231 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,502,389 | $11,170,067 | $6,459,717 | $7,324,881 |
| End Cash | $9,391,450 | $9,502,389 | $11,170,067 | $6,450,650 |
| Free Cash Flow | $66,790 | -$1,922,488 | -$1,671,268 | -$1,023,840 |